72516-021-01 : NDC 2026 Code

72516-021-01 : Carbamazepine ( Carbamazepine )

Additionally :

You can get information about “72516-021-01” NDC code in 72516-021-01 in HTML format

HTML | 72516-021-01 in TXT (Plain Text) format

TXT | 72516-021-01 in PDF (Portable Document Format)

PDF | 72516-021-01 in XML format

XML formats.

NDC Code : 72516-021-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72516-021-01",
    "PackageDescription": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72516-021-01) ",
    "NDC11Code": "72516-0021-01",
    "ProductNDC": "72516-021",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Carbamazepine",
    "ProprietaryNameSuffix": "Er",
    "NonProprietaryName": "Carbamazepine",
    "DosageFormName": "TABLET, EXTENDED RELEASE",
    "RouteName": "ORAL",
    "StartMarketingDate": "20260518",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA212948",
    "LabelerName": "Oryza Pharmaceuticals Inc.",
    "SubstanceName": "CARBAMAZEPINE",
    "StrengthNumber": "400",
    "StrengthUnit": "mg/1",
    "Pharm_Classes": "Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mood Stabilizer [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2026-05-19",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20271231",
    "StartMarketingDatePackage": "20260518",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}